Drug Screening Market Size, Share & Trends Analysis Report By Product Type (Instruments, Rapid Testing Devices), By Sample Type (Urine Sample, Breath Sample), By End-use, By Region, And Segment Forecasts, 2024 - 2030
This report can be delivered to the clients within 3 Business Days
Drug Screening Market Growth & Trends
The global drug screening market size is anticipated to reach USD 11.99 billion by 2030 and is growing at a CAGR of 4.0% during the forecast period, according to a new report by Grand View Research, Inc. The market is driven by increasing workplace safety concerns, regulatory compliance, and requirement for accurate detection of substance abuse, aided by technological advancements in testing methods.
The increase in number of adults in contact with drug and alcohol services in England has increased from 275,896 in 2020 - 2021¬ to 289,215 in 2021 - 2022, representing a 4.8% rise, which signifies a growing prevalence of substance abuse in the country. The rising prevalence of substance abuse further propels the need for effective prevention and treatment strategies, including the expansion of access to evidence-based treatment options and public health campaigns to raise awareness about the risks of drug and alcohol misuse.
Similarly, the incidence of illegal substance use among Americans aged 12 and older in 2020 was around 37.31 million, and shows a 3.8% year-over-year increase over the years; this rising prevalence serves as a significant driver for the market. This increase highlights the urgent need for comprehensive drug screening programs in workplaces, schools, and healthcare settings to ensure safety, compliance with regulations, and provision of appropriate care and support for individuals struggling with substance abuse.
Furthermore, initiatives by market players such as new product launches, mergers, acquisitions, and others contribute to market growth. For instance, in February 2024, Mobile Health, the leading drug testing provider in NYC, introduced rapid drug testing for employers, ensuring results in an hour or less. With a focus on urine-based testing for accuracy and versatility, this innovation advances the hiring process, revolutionizing talent acquisition in NYC. In addition, in December 2023, the FDA's approval of the AvertD test, which assesses an individual's risk of developing opioid use disorder through genetic markers, marks a significant innovation in the fight against the opioid crisis. This test, developed by AutoGenomics, Inc., is designed to be used before a patient is first exposed to oral opioid pain medications, particularly in patients scheduled for surgical procedures. The test is intended to help patients and healthcare providers make informed decisions about opioid use, potentially reducing the risk of addiction and misuse.
The approval of AvertD is part of FDA's broader efforts to address opioid crisis, which includes the introduction of FDA Overdose Prevention Framework in August 2022 and the approval of nonprescription naloxone nasal spray products in March and July 2023. The FDA's commitment to addressing these crisis is evident in its continued support for the development of medical devices that can help assess and mitigate the risk of opioid use disorder.
Drug Screening Market Report Highlights
Drug Screening Market Growth & Trends
The global drug screening market size is anticipated to reach USD 11.99 billion by 2030 and is growing at a CAGR of 4.0% during the forecast period, according to a new report by Grand View Research, Inc. The market is driven by increasing workplace safety concerns, regulatory compliance, and requirement for accurate detection of substance abuse, aided by technological advancements in testing methods.
The increase in number of adults in contact with drug and alcohol services in England has increased from 275,896 in 2020 - 2021¬ to 289,215 in 2021 - 2022, representing a 4.8% rise, which signifies a growing prevalence of substance abuse in the country. The rising prevalence of substance abuse further propels the need for effective prevention and treatment strategies, including the expansion of access to evidence-based treatment options and public health campaigns to raise awareness about the risks of drug and alcohol misuse.
Similarly, the incidence of illegal substance use among Americans aged 12 and older in 2020 was around 37.31 million, and shows a 3.8% year-over-year increase over the years; this rising prevalence serves as a significant driver for the market. This increase highlights the urgent need for comprehensive drug screening programs in workplaces, schools, and healthcare settings to ensure safety, compliance with regulations, and provision of appropriate care and support for individuals struggling with substance abuse.
Furthermore, initiatives by market players such as new product launches, mergers, acquisitions, and others contribute to market growth. For instance, in February 2024, Mobile Health, the leading drug testing provider in NYC, introduced rapid drug testing for employers, ensuring results in an hour or less. With a focus on urine-based testing for accuracy and versatility, this innovation advances the hiring process, revolutionizing talent acquisition in NYC. In addition, in December 2023, the FDA's approval of the AvertD test, which assesses an individual's risk of developing opioid use disorder through genetic markers, marks a significant innovation in the fight against the opioid crisis. This test, developed by AutoGenomics, Inc., is designed to be used before a patient is first exposed to oral opioid pain medications, particularly in patients scheduled for surgical procedures. The test is intended to help patients and healthcare providers make informed decisions about opioid use, potentially reducing the risk of addiction and misuse.
The approval of AvertD is part of FDA's broader efforts to address opioid crisis, which includes the introduction of FDA Overdose Prevention Framework in August 2022 and the approval of nonprescription naloxone nasal spray products in March and July 2023. The FDA's commitment to addressing these crisis is evident in its continued support for the development of medical devices that can help assess and mitigate the risk of opioid use disorder.
Drug Screening Market Report Highlights
- Consumables dominated the product type segment with the fastest revenue market share in 2023 and is anticipated to grow at fastest growth rate over the forecast period owing to extensive R&D initiatives undertaken by major players to develop kits
- Based on type segment, urine sample dominated the market with the largest revenue share in 2023 attributed to the ease of collection. Urine drug testing is generally more cost-effective compared to other testing methods, such as hair testing
- Drug treatment centers end-use segment dominated the market in 2023, attributed to the increasing focus on substance abuse treatment and rehabilitation, leading to a higher demand for drug testing services in these centers
- North America dominated the global market owing to factors such as advanced healthcare infrastructure, the region’s high consumption of illegal substances, and the necessity for workplace drug tests
CHAPTER 1. METHODOLOGY AND SCOPE
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Product Type
1.2.2. Sample Type
1.2.3. End-use
1.2.4. Regional scope
1.2.5. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.4.5.1. Data for primary interviews in North America
1.4.5.2. Data for primary interviews in Europe
1.4.5.3. Data for primary interviews in Asia Pacific
1.4.5.4. Data for primary interviews in Latin America
1.4.5.5. Data for Primary interviews in MEA
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product type outlook
2.2.2. Sample type outlook
2.2.3. End-use outlook
2.2.4. Regional outlook
2.3. Competitive Insights
CHAPTER 3. DRUG SCREENING MARKET VARIABLES, TRENDS & SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Increasing drug and alcohol consumption
3.2.1.2. Growing demand for drug screening measures
3.2.1.3. Rise in government funding
3.2.2. Market restraint analysis
3.2.2.1. Rising false positive and negative results in drug screeni9ng limits screening process
3.2.2.2. Rise in privacy concerns limiting the expansion of drug screening practices
3.3. Drug Screening Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
3.3.3. Pricing Analysis
CHAPTER 4. DRUG SCREENING MARKET: PRODUCT TYPE ESTIMATES & TREND ANALYSIS
4.1. Global Drug Screening Market: Product Type Dashboard
4.2. Global Drug Screening Market: Product Type Movement Analysis
4.3. Global Drug Screening Market by Product Type, Revenue
4.4. Instruments
4.4.1. Instruments market estimates and forecasts 2018 - 2030 (USD Million)
4.4.2. Immunoassays Analyzers
4.4.2.1. Market estimates and forecasts 2018 - 2030 (USD Million)
4.4.3. Chromatography Instruments
4.4.3.1. Market estimates and forecasts 2018 - 2030 (USD Million)
4.4.4. Breath Analyzer
4.4.4.1. Market estimates and forecasts 2018 - 2030 (USD Million)
4.4.4.2. Fuel Cell Breath Analyzer
4.4.4.2.1. Market estimates and forecasts 2018 - 2030 (USD Million)
4.4.4.3. Semi-conductor Breath Analyzer
4.4.4.3.1. Market estimates and forecasts 2018 - 2030 (USD Million)
4.4.4.4. Others Breath Analyzer
4.4.4.4.1. Market estimates and forecasts 2018 - 2030 (USD Million)
4.5. Rapid Testing Devices
4.5.1. Rapid testing devices market estimates and forecasts 2018 - 2030 (USD Million)
4.5.2. Urine Testing Devices
4.5.2.1. Market estimates and forecasts 2018 - 2030 (USD Million)
4.5.2.2. Drug Testing Cups
4.5.2.2.1. Market estimates and forecasts 2018 - 2030 (USD Million)
4.5.2.3. Dip Cards
4.5.2.3.1. Market estimates and forecasts 2018 - 2030 (USD Million)
4.5.2.4. Drug Testing Cassettes
4.5.2.4.1. Market estimates and forecasts 2018 - 2030 (USD Million)
4.5.3. Oral Fluid Testing Devices
4.5.3.1. Market estimates and forecasts 2018 - 2030 (USD Million)
4.6. Consumables
4.6.1. Consumables market estimates and forecasts 2018 - 2030 (USD Million)
4.6.2. Assay Kits
4.6.2.1. Market estimates and forecasts 2018 - 2030 (USD Million)
4.6.3. Sample Collection Devices
4.6.3.1. Market estimates and forecasts 2018 - 2030 (USD Million)
4.6.4. Calibrators & Controls
4.6.4.1. Market estimates and forecasts 2018 - 2030 (USD Million)
4.6.5. Other Consumables
4.6.5.1. Market estimates and forecasts 2018 - 2030 (USD Million)
4.7. Services and Others
4.7.1. Services and others market estimates and forecasts 2018 - 2030 (USD Million)
CHAPTER 5. DRUG SCREENING MARKET: TECHNOLOGY ESTIMATES & TREND ANALYSIS
5.1. Global Drug Screening Market: Sample Type Dashboard
5.2. Global Drug Screening Market: Sample Type Movement Analysis
5.3. Global Drug Screening Market by Sample Type, Revenue
5.4. Urine Samples
5.4.1. Urine samples market estimates and forecasts 2018 - 2030 (USD Million)
5.5. Breath Samples
5.5.1. Breath samples market estimates and forecasts 2018 - 2030 (USD Million)
5.6. Oral Fluid Samples
5.6.1. Oral fluid samples market estimates and forecasts 2018 - 2030 (USD Million)
5.7. Hair Samples
5.7.1. Hair samples market estimates and forecasts 2018 - 2030 (USD Million)
5.8. Other Samples
5.8.1. Other samples market estimates and forecasts 2018 - 2030 (USD Million)
CHAPTER 6. DRUG SCREENING MARKET: END-USE ESTIMATES & TREND ANALYSIS
6.1. Global Drug Screening Market: End-use Dashboard
6.2. Global Drug Screening Market: End-use Movement Analysis
6.3. Global Drug Screening Market by End-use, Revenue
6.4. Hospitals
6.4.1. Hospitals market estimates and forecasts 2018 - 2030 (USD Million)
6.5. Criminal Justice & Law Enforcement Agencies
6.5.1. Clinical laboratories market estimates and forecasts 2018 - 2030 (USD Million)
6.6. Workplaces
6.6.1. Workplaces market estimates and forecasts 2018 - 2030 (USD Million)
6.7. Drug Treatment Centers
6.7.1. Drug treatment centers market estimates and forecasts 2018 - 2030 (USD Million)
6.8. Individual Users
6.8.1. Individual users market estimates and forecasts 2018 - 2030 (USD Million)
6.9. Pain Management Centers
6.9.1. Pain management centers market estimates and forecasts 2018 - 2030 (USD Million)
6.10. Schools & Colleges
6.10.1. Schools & Colleges market estimates and forecasts 2018 - 2030 (USD Million)
6.11. Others
6.11.1. Others market estimates and forecasts 2018 - 2030 (USD Million)
CHAPTER 7. DRUG SCREENING MARKET: REGIONAL ESTIMATES & TREND ANALYSIS BY PRODUCT TYPE, SAMPLE TYPE, AND END-USE
7.1. Regional Dashboard
7.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
7.3. North America
7.3.1. U.S.
7.3.1.1. Key country dynamics
7.3.1.2. Regulatory framework/ reimbursement structure
7.3.1.3. Competitive scenario
7.3.1.4. U.S. market estimates and forecasts 2018 - 2030 (USD Million)
7.3.2. Canada
7.3.2.1. Key country dynamics
7.3.2.2. Regulatory framework/ reimbursement structure
7.3.2.3. Competitive scenario
7.3.2.4. Canada market estimates and forecasts 2018 - 2030 (USD Million)
7.3.3. Mexico
7.3.3.1. Key country dynamics
7.3.3.2. Regulatory framework/ reimbursement structure
7.3.3.3. Competitive scenario
7.3.3.4. Mexico market estimates and forecasts 2018 - 2030 (USD Million)
7.4. Europe
7.4.1. UK
7.4.1.1. Key country dynamics
7.4.1.2. Regulatory framework/ reimbursement structure
7.4.1.3. Competitive scenario
7.4.1.4. UK market estimates and forecasts 2018 - 2030 (USD Million)
7.4.2. Germany
7.4.2.1. Key country dynamics
7.4.2.2. Regulatory framework/ reimbursement structure
7.4.2.3. Competitive scenario
7.4.2.4. Germany market estimates and forecasts 2018 - 2030 (USD Million)
7.4.3. France
7.4.3.1. Key country dynamics
7.4.3.2. Regulatory framework/ reimbursement structure
7.4.3.3. Competitive scenario
7.4.3.4. France market estimates and forecasts 2018 - 2030 (USD Million)
7.4.4. Italy
7.4.4.1. Key country dynamics
7.4.4.2. Regulatory framework/ reimbursement structure
7.4.4.3. Competitive scenario
7.4.4.4. Italy market estimates and forecasts 2018 - 2030 (USD Million)
7.4.5. Spain
7.4.5.1. Key country dynamics
7.4.5.2. Regulatory framework/ reimbursement structure
7.4.5.3. Competitive scenario
7.4.5.4. Spain market estimates and forecasts 2018 - 2030 (USD Million)
7.4.6. Denmark
7.4.6.1. Key country dynamics
7.4.6.2. Regulatory framework/ reimbursement structure
7.4.6.3. Competitive scenario
7.4.6.4. Denmark market estimates and forecasts 2018 - 2030 (USD Million)
7.4.7. Sweden
7.4.7.1. Key country dynamics
7.4.7.2. Regulatory framework/ reimbursement structure
7.4.7.3. Competitive scenario
7.4.7.4. Sweden market estimates and forecasts 2018 - 2030 (USD Million)
7.4.8. Norway
7.4.8.1. Key country dynamics
7.4.8.2. Regulatory framework/ reimbursement structure
7.4.8.3. Competitive scenario
7.4.8.4. Norway market estimates and forecasts 2018 - 2030 (USD Million)
7.5. Asia Pacific
7.5.1. Japan
7.5.1.1. Key country dynamics
7.5.1.2. Regulatory framework/ reimbursement structure
7.5.1.3. Competitive scenario
7.5.1.4. Japan market estimates and forecasts 2018 - 2030 (USD Million)
7.5.2. China
7.5.2.1. Key country dynamics
7.5.2.2. Regulatory framework/ reimbursement structure
7.5.2.3. Competitive scenario
7.5.2.4. China market estimates and forecasts 2018 - 2030 (USD Million)
7.5.3. India
7.5.3.1. Key country dynamics
7.5.3.2. Regulatory framework/ reimbursement structure
7.5.3.3. Competitive scenario
7.5.3.4. India market estimates and forecasts 2018 - 2030 (USD Million)
7.5.4. Australia
7.5.4.1. Key country dynamics
7.5.4.2. Regulatory framework/ reimbursement structure
7.5.4.3. Competitive scenario
7.5.4.4. Australia market estimates and forecasts 2018 - 2030 (USD Million)
7.5.5. South Korea
7.5.5.1. Key country dynamics
7.5.5.2. Regulatory framework/ reimbursement structure
7.5.5.3. Competitive scenario
7.5.5.4. South Korea market estimates and forecasts 2018 - 2030 (USD Million)
7.5.6. Thailand
7.5.6.1. Key country dynamics
7.5.6.2. Regulatory framework/ reimbursement structure
7.5.6.3. Competitive scenario
7.5.6.4. Thailand market estimates and forecasts 2018 - 2030 (USD Million)
7.6. Latin America
7.6.1. Brazil
7.6.1.1. Key country dynamics
7.6.1.2. Regulatory framework/ reimbursement structure
7.6.1.3. Competitive scenario
7.6.1.4. Brazil market estimates and forecasts 2018 - 2030 (USD Million)
7.6.2. Argentina
7.6.2.1. Key country dynamics
7.6.2.2. Regulatory framework/ reimbursement structure
7.6.2.3. Competitive scenario
7.6.2.4. Argentina market estimates and forecasts 2018 - 2030 (USD Million)
7.7. MEA
7.7.1. South Africa
7.7.1.1. Key country dynamics
7.7.1.2. Regulatory framework/ reimbursement structure
7.7.1.3. Competitive scenario
7.7.1.4. South Africa market estimates and forecasts 2018 - 2030 (USD Million)
7.7.2. Saudi Arabia
7.7.2.1. Key country dynamics
7.7.2.2. Regulatory framework/ reimbursement structure
7.7.2.3. Competitive scenario
7.7.2.4. Saudi Arabia market estimates and forecasts 2018 - 2030 (USD Million)
7.7.3. UAE
7.7.3.1. Key country dynamics
7.7.3.2. Regulatory framework/ reimbursement structure
7.7.3.3. Competitive scenario
7.7.3.4. UAE market estimates and forecasts 2018 - 2030 (USD Million)
7.7.4. Kuwait
7.7.4.1. Key country dynamics
7.7.4.2. Regulatory framework/ reimbursement structure
7.7.4.3. Competitive scenario
7.7.4.4. Kuwait market estimates and forecasts 2018 - 2030 (USD Million)
CHAPTER 8. COMPETITIVE LANDSCAPE
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Company/Competition Categorization
8.3. Vendor Landscape
8.3.1. List of key distributors and channel partners
8.3.2. Key customers
8.3.3. Key company market share analysis, 2023
8.3.4. Abbott
8.3.4.1. Company overview
8.3.4.2. Financial performance
8.3.4.3. Product benchmarking
8.3.4.4. Strategic initiatives
8.3.5. Quest Diagnostics Incorporated
8.3.5.1. Company overview
8.3.5.2. Financial performance
8.3.5.3. Product benchmarking
8.3.5.4. Strategic initiatives
8.3.6. F. Hoffmann-La Roche Ltd
8.3.6.1. Company overview
8.3.6.2. Financial performance
8.3.6.3. Product benchmarking
8.3.6.4. Strategic initiatives
8.3.7. Thermo Fisher Scientific Inc.
8.3.7.1. Company overview
8.3.7.2. Financial performance
8.3.7.3. Product benchmarking
8.3.7.4. Strategic initiatives
8.3.8. Siemens Healthcare AG
8.3.8.1. Company overview
8.3.8.2. Financial performance
8.3.8.3. Product benchmarking
8.3.8.4. Strategic initiatives
8.3.9. Laboratory Corporation of America Holdings
8.3.9.1. Company overview
8.3.9.2. Financial performance
8.3.9.3. Product benchmarking
8.3.9.4. Strategic initiatives
8.3.10. Alfa Scientific Designs, Inc.,
8.3.10.1. Company overview
8.3.10.2. Financial performance
8.3.10.3. Product benchmarking
8.3.10.4. Strategic initiatives
8.3.11. OraSure Technologies, Inc.
8.3.11.1. Company overview
8.3.11.2. Financial performance
8.3.11.3. Product benchmarking
8.3.11.4. Strategic initiatives
8.3.12. Omega Laboratories, Inc.
8.3.12.1. Company overview
8.3.12.2. Financial performance
8.3.12.3. Product benchmarking
8.3.12.4. Strategic initiatives
8.3.13. Drдgerwerk AG & Co. KGaA
8.3.13.1. Company overview
8.3.13.2. Financial performance
8.3.13.3. Product benchmarking
8.3.13.4. Strategic initiatives
8.3.14. Bio-Rad Laboratories, Inc.
8.3.14.1. Company overview
8.3.14.2. Financial performance
8.3.14.3. Product benchmarking
8.3.14.4. Strategic initiatives
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Product Type
1.2.2. Sample Type
1.2.3. End-use
1.2.4. Regional scope
1.2.5. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.4.5.1. Data for primary interviews in North America
1.4.5.2. Data for primary interviews in Europe
1.4.5.3. Data for primary interviews in Asia Pacific
1.4.5.4. Data for primary interviews in Latin America
1.4.5.5. Data for Primary interviews in MEA
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product type outlook
2.2.2. Sample type outlook
2.2.3. End-use outlook
2.2.4. Regional outlook
2.3. Competitive Insights
CHAPTER 3. DRUG SCREENING MARKET VARIABLES, TRENDS & SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Increasing drug and alcohol consumption
3.2.1.2. Growing demand for drug screening measures
3.2.1.3. Rise in government funding
3.2.2. Market restraint analysis
3.2.2.1. Rising false positive and negative results in drug screeni9ng limits screening process
3.2.2.2. Rise in privacy concerns limiting the expansion of drug screening practices
3.3. Drug Screening Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
3.3.3. Pricing Analysis
CHAPTER 4. DRUG SCREENING MARKET: PRODUCT TYPE ESTIMATES & TREND ANALYSIS
4.1. Global Drug Screening Market: Product Type Dashboard
4.2. Global Drug Screening Market: Product Type Movement Analysis
4.3. Global Drug Screening Market by Product Type, Revenue
4.4. Instruments
4.4.1. Instruments market estimates and forecasts 2018 - 2030 (USD Million)
4.4.2. Immunoassays Analyzers
4.4.2.1. Market estimates and forecasts 2018 - 2030 (USD Million)
4.4.3. Chromatography Instruments
4.4.3.1. Market estimates and forecasts 2018 - 2030 (USD Million)
4.4.4. Breath Analyzer
4.4.4.1. Market estimates and forecasts 2018 - 2030 (USD Million)
4.4.4.2. Fuel Cell Breath Analyzer
4.4.4.2.1. Market estimates and forecasts 2018 - 2030 (USD Million)
4.4.4.3. Semi-conductor Breath Analyzer
4.4.4.3.1. Market estimates and forecasts 2018 - 2030 (USD Million)
4.4.4.4. Others Breath Analyzer
4.4.4.4.1. Market estimates and forecasts 2018 - 2030 (USD Million)
4.5. Rapid Testing Devices
4.5.1. Rapid testing devices market estimates and forecasts 2018 - 2030 (USD Million)
4.5.2. Urine Testing Devices
4.5.2.1. Market estimates and forecasts 2018 - 2030 (USD Million)
4.5.2.2. Drug Testing Cups
4.5.2.2.1. Market estimates and forecasts 2018 - 2030 (USD Million)
4.5.2.3. Dip Cards
4.5.2.3.1. Market estimates and forecasts 2018 - 2030 (USD Million)
4.5.2.4. Drug Testing Cassettes
4.5.2.4.1. Market estimates and forecasts 2018 - 2030 (USD Million)
4.5.3. Oral Fluid Testing Devices
4.5.3.1. Market estimates and forecasts 2018 - 2030 (USD Million)
4.6. Consumables
4.6.1. Consumables market estimates and forecasts 2018 - 2030 (USD Million)
4.6.2. Assay Kits
4.6.2.1. Market estimates and forecasts 2018 - 2030 (USD Million)
4.6.3. Sample Collection Devices
4.6.3.1. Market estimates and forecasts 2018 - 2030 (USD Million)
4.6.4. Calibrators & Controls
4.6.4.1. Market estimates and forecasts 2018 - 2030 (USD Million)
4.6.5. Other Consumables
4.6.5.1. Market estimates and forecasts 2018 - 2030 (USD Million)
4.7. Services and Others
4.7.1. Services and others market estimates and forecasts 2018 - 2030 (USD Million)
CHAPTER 5. DRUG SCREENING MARKET: TECHNOLOGY ESTIMATES & TREND ANALYSIS
5.1. Global Drug Screening Market: Sample Type Dashboard
5.2. Global Drug Screening Market: Sample Type Movement Analysis
5.3. Global Drug Screening Market by Sample Type, Revenue
5.4. Urine Samples
5.4.1. Urine samples market estimates and forecasts 2018 - 2030 (USD Million)
5.5. Breath Samples
5.5.1. Breath samples market estimates and forecasts 2018 - 2030 (USD Million)
5.6. Oral Fluid Samples
5.6.1. Oral fluid samples market estimates and forecasts 2018 - 2030 (USD Million)
5.7. Hair Samples
5.7.1. Hair samples market estimates and forecasts 2018 - 2030 (USD Million)
5.8. Other Samples
5.8.1. Other samples market estimates and forecasts 2018 - 2030 (USD Million)
CHAPTER 6. DRUG SCREENING MARKET: END-USE ESTIMATES & TREND ANALYSIS
6.1. Global Drug Screening Market: End-use Dashboard
6.2. Global Drug Screening Market: End-use Movement Analysis
6.3. Global Drug Screening Market by End-use, Revenue
6.4. Hospitals
6.4.1. Hospitals market estimates and forecasts 2018 - 2030 (USD Million)
6.5. Criminal Justice & Law Enforcement Agencies
6.5.1. Clinical laboratories market estimates and forecasts 2018 - 2030 (USD Million)
6.6. Workplaces
6.6.1. Workplaces market estimates and forecasts 2018 - 2030 (USD Million)
6.7. Drug Treatment Centers
6.7.1. Drug treatment centers market estimates and forecasts 2018 - 2030 (USD Million)
6.8. Individual Users
6.8.1. Individual users market estimates and forecasts 2018 - 2030 (USD Million)
6.9. Pain Management Centers
6.9.1. Pain management centers market estimates and forecasts 2018 - 2030 (USD Million)
6.10. Schools & Colleges
6.10.1. Schools & Colleges market estimates and forecasts 2018 - 2030 (USD Million)
6.11. Others
6.11.1. Others market estimates and forecasts 2018 - 2030 (USD Million)
CHAPTER 7. DRUG SCREENING MARKET: REGIONAL ESTIMATES & TREND ANALYSIS BY PRODUCT TYPE, SAMPLE TYPE, AND END-USE
7.1. Regional Dashboard
7.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
7.3. North America
7.3.1. U.S.
7.3.1.1. Key country dynamics
7.3.1.2. Regulatory framework/ reimbursement structure
7.3.1.3. Competitive scenario
7.3.1.4. U.S. market estimates and forecasts 2018 - 2030 (USD Million)
7.3.2. Canada
7.3.2.1. Key country dynamics
7.3.2.2. Regulatory framework/ reimbursement structure
7.3.2.3. Competitive scenario
7.3.2.4. Canada market estimates and forecasts 2018 - 2030 (USD Million)
7.3.3. Mexico
7.3.3.1. Key country dynamics
7.3.3.2. Regulatory framework/ reimbursement structure
7.3.3.3. Competitive scenario
7.3.3.4. Mexico market estimates and forecasts 2018 - 2030 (USD Million)
7.4. Europe
7.4.1. UK
7.4.1.1. Key country dynamics
7.4.1.2. Regulatory framework/ reimbursement structure
7.4.1.3. Competitive scenario
7.4.1.4. UK market estimates and forecasts 2018 - 2030 (USD Million)
7.4.2. Germany
7.4.2.1. Key country dynamics
7.4.2.2. Regulatory framework/ reimbursement structure
7.4.2.3. Competitive scenario
7.4.2.4. Germany market estimates and forecasts 2018 - 2030 (USD Million)
7.4.3. France
7.4.3.1. Key country dynamics
7.4.3.2. Regulatory framework/ reimbursement structure
7.4.3.3. Competitive scenario
7.4.3.4. France market estimates and forecasts 2018 - 2030 (USD Million)
7.4.4. Italy
7.4.4.1. Key country dynamics
7.4.4.2. Regulatory framework/ reimbursement structure
7.4.4.3. Competitive scenario
7.4.4.4. Italy market estimates and forecasts 2018 - 2030 (USD Million)
7.4.5. Spain
7.4.5.1. Key country dynamics
7.4.5.2. Regulatory framework/ reimbursement structure
7.4.5.3. Competitive scenario
7.4.5.4. Spain market estimates and forecasts 2018 - 2030 (USD Million)
7.4.6. Denmark
7.4.6.1. Key country dynamics
7.4.6.2. Regulatory framework/ reimbursement structure
7.4.6.3. Competitive scenario
7.4.6.4. Denmark market estimates and forecasts 2018 - 2030 (USD Million)
7.4.7. Sweden
7.4.7.1. Key country dynamics
7.4.7.2. Regulatory framework/ reimbursement structure
7.4.7.3. Competitive scenario
7.4.7.4. Sweden market estimates and forecasts 2018 - 2030 (USD Million)
7.4.8. Norway
7.4.8.1. Key country dynamics
7.4.8.2. Regulatory framework/ reimbursement structure
7.4.8.3. Competitive scenario
7.4.8.4. Norway market estimates and forecasts 2018 - 2030 (USD Million)
7.5. Asia Pacific
7.5.1. Japan
7.5.1.1. Key country dynamics
7.5.1.2. Regulatory framework/ reimbursement structure
7.5.1.3. Competitive scenario
7.5.1.4. Japan market estimates and forecasts 2018 - 2030 (USD Million)
7.5.2. China
7.5.2.1. Key country dynamics
7.5.2.2. Regulatory framework/ reimbursement structure
7.5.2.3. Competitive scenario
7.5.2.4. China market estimates and forecasts 2018 - 2030 (USD Million)
7.5.3. India
7.5.3.1. Key country dynamics
7.5.3.2. Regulatory framework/ reimbursement structure
7.5.3.3. Competitive scenario
7.5.3.4. India market estimates and forecasts 2018 - 2030 (USD Million)
7.5.4. Australia
7.5.4.1. Key country dynamics
7.5.4.2. Regulatory framework/ reimbursement structure
7.5.4.3. Competitive scenario
7.5.4.4. Australia market estimates and forecasts 2018 - 2030 (USD Million)
7.5.5. South Korea
7.5.5.1. Key country dynamics
7.5.5.2. Regulatory framework/ reimbursement structure
7.5.5.3. Competitive scenario
7.5.5.4. South Korea market estimates and forecasts 2018 - 2030 (USD Million)
7.5.6. Thailand
7.5.6.1. Key country dynamics
7.5.6.2. Regulatory framework/ reimbursement structure
7.5.6.3. Competitive scenario
7.5.6.4. Thailand market estimates and forecasts 2018 - 2030 (USD Million)
7.6. Latin America
7.6.1. Brazil
7.6.1.1. Key country dynamics
7.6.1.2. Regulatory framework/ reimbursement structure
7.6.1.3. Competitive scenario
7.6.1.4. Brazil market estimates and forecasts 2018 - 2030 (USD Million)
7.6.2. Argentina
7.6.2.1. Key country dynamics
7.6.2.2. Regulatory framework/ reimbursement structure
7.6.2.3. Competitive scenario
7.6.2.4. Argentina market estimates and forecasts 2018 - 2030 (USD Million)
7.7. MEA
7.7.1. South Africa
7.7.1.1. Key country dynamics
7.7.1.2. Regulatory framework/ reimbursement structure
7.7.1.3. Competitive scenario
7.7.1.4. South Africa market estimates and forecasts 2018 - 2030 (USD Million)
7.7.2. Saudi Arabia
7.7.2.1. Key country dynamics
7.7.2.2. Regulatory framework/ reimbursement structure
7.7.2.3. Competitive scenario
7.7.2.4. Saudi Arabia market estimates and forecasts 2018 - 2030 (USD Million)
7.7.3. UAE
7.7.3.1. Key country dynamics
7.7.3.2. Regulatory framework/ reimbursement structure
7.7.3.3. Competitive scenario
7.7.3.4. UAE market estimates and forecasts 2018 - 2030 (USD Million)
7.7.4. Kuwait
7.7.4.1. Key country dynamics
7.7.4.2. Regulatory framework/ reimbursement structure
7.7.4.3. Competitive scenario
7.7.4.4. Kuwait market estimates and forecasts 2018 - 2030 (USD Million)
CHAPTER 8. COMPETITIVE LANDSCAPE
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Company/Competition Categorization
8.3. Vendor Landscape
8.3.1. List of key distributors and channel partners
8.3.2. Key customers
8.3.3. Key company market share analysis, 2023
8.3.4. Abbott
8.3.4.1. Company overview
8.3.4.2. Financial performance
8.3.4.3. Product benchmarking
8.3.4.4. Strategic initiatives
8.3.5. Quest Diagnostics Incorporated
8.3.5.1. Company overview
8.3.5.2. Financial performance
8.3.5.3. Product benchmarking
8.3.5.4. Strategic initiatives
8.3.6. F. Hoffmann-La Roche Ltd
8.3.6.1. Company overview
8.3.6.2. Financial performance
8.3.6.3. Product benchmarking
8.3.6.4. Strategic initiatives
8.3.7. Thermo Fisher Scientific Inc.
8.3.7.1. Company overview
8.3.7.2. Financial performance
8.3.7.3. Product benchmarking
8.3.7.4. Strategic initiatives
8.3.8. Siemens Healthcare AG
8.3.8.1. Company overview
8.3.8.2. Financial performance
8.3.8.3. Product benchmarking
8.3.8.4. Strategic initiatives
8.3.9. Laboratory Corporation of America Holdings
8.3.9.1. Company overview
8.3.9.2. Financial performance
8.3.9.3. Product benchmarking
8.3.9.4. Strategic initiatives
8.3.10. Alfa Scientific Designs, Inc.,
8.3.10.1. Company overview
8.3.10.2. Financial performance
8.3.10.3. Product benchmarking
8.3.10.4. Strategic initiatives
8.3.11. OraSure Technologies, Inc.
8.3.11.1. Company overview
8.3.11.2. Financial performance
8.3.11.3. Product benchmarking
8.3.11.4. Strategic initiatives
8.3.12. Omega Laboratories, Inc.
8.3.12.1. Company overview
8.3.12.2. Financial performance
8.3.12.3. Product benchmarking
8.3.12.4. Strategic initiatives
8.3.13. Drдgerwerk AG & Co. KGaA
8.3.13.1. Company overview
8.3.13.2. Financial performance
8.3.13.3. Product benchmarking
8.3.13.4. Strategic initiatives
8.3.14. Bio-Rad Laboratories, Inc.
8.3.14.1. Company overview
8.3.14.2. Financial performance
8.3.14.3. Product benchmarking
8.3.14.4. Strategic initiatives
LIST OF TABLES
Table 1 List of abbreviation
Table 2 North America drug screening market, by region, 2018 - 2030 (USD Million)
Table 3 North America drug screening market, by product type, 2018 - 2030 (USD Million)
Table 4 North America drug screening market, by sample type, 2018 - 2030 (USD Million)
Table 5 North America drug screening market, by end-use, 2018 - 2030 (USD Million)
Table 6 U.S. drug screening market, by product type, 2018 - 2030 (USD Million)
Table 7 U.S. drug screening market, by sample type, 2018 - 2030 (USD Million)
Table 8 U.S. drug screening market, by end-use, 2018 - 2030 (USD Million)
Table 9 Canada drug screening market, by product type, 2018 - 2030 (USD Million)
Table 10 Canada drug screening market, by sample type, 2018 - 2030 (USD Million)
Table 11 Canada drug screening market, by end-use, 2018 - 2030 (USD Million)
Table 12 Mexico drug screening market, by product type, 2018 - 2030 (USD Million)
Table 13 Mexico drug screening market, by sample type, 2018 - 2030 (USD Million)
Table 14 Mexico drug screening market, by end-use, 2018 - 2030 (USD Million)
Table 15 Europe drug screening market, by region, 2018 - 2030 (USD Million)
Table 16 Europe drug screening market, by product type, 2018 - 2030 (USD Million)
Table 17 Europe drug screening market, by sample type, 2018 - 2030 (USD Million)
Table 18 Europe drug screening market, by end-use, 2018 - 2030 (USD Million)
Table 19 UK drug screening market, by product type, 2018 - 2030 (USD Million)
Table 20 UK drug screening market, by sample type, 2018 - 2030 (USD Million)
Table 21 UK drug screening market, by end-use, 2018 - 2030 (USD Million)
Table 22 Germany drug screening market, by product type, 2018 - 2030 (USD Million)
Table 23 Germany drug screening market, by sample type, 2018 - 2030 (USD Million)
Table 24 Germany drug screening market, by end-use, 2018 - 2030 (USD Million)
Table 25 France drug screening market, by product type, 2018 - 2030 (USD Million)
Table 26 France drug screening market, by sample type, 2018 - 2030 (USD Million)
Table 27 France drug screening market, by end-use, 2018 - 2030 (USD Million)
Table 28 Italy drug screening market, by product type, 2018 - 2030 (USD Million)
Table 29 Italy drug screening market, by sample type, 2018 - 2030 (USD Million)
Table 30 Italy drug screening market, by end-use, 2018 - 2030 (USD Million)
Table 31 Spain drug screening market, by product type, 2018 - 2030 (USD Million)
Table 32 Spain drug screening market, by sample type, 2018 - 2030 (USD Million)
Table 33 Spain drug screening market, by end-use, 2018 - 2030 (USD Million)
Table 34 Denmark drug screening market, by product type, 2018 - 2030 (USD Million)
Table 35 Denmark drug screening market, by sample type, 2018 - 2030 (USD Million)
Table 36 Denmark drug screening market, by end-use, 2018 - 2030 (USD Million)
Table 37 Sweden drug screening market, by product type, 2018 - 2030 (USD Million)
Table 38 Sweden drug screening market, by sample type, 2018 - 2030 (USD Million)
Table 39 Sweden drug screening market, by end-use, 2018 - 2030 (USD Million)
Table 40 Norway drug screening market, by product type, 2018 - 2030 (USD Million)
Table 41 Norway drug screening market, by sample type, 2018 - 2030 (USD Million)
Table 42 Norway drug screening market, by end-use, 2018 - 2030 (USD Million)
Table 43 Asia Pacific drug screening market, by region, 2018 - 2030 (USD Million)
Table 44 Asia Pacific drug screening market, by product type, 2018 - 2030 (USD Million)
Table 45 Asia Pacific drug screening market, by sample type, 2018 - 2030 (USD Million)
Table 46 Aisa Pacific drug screening market, by end-use, 2018 - 2030 (USD Million)
Table 47 Japan drug screening market, by product type, 2018 - 2030 (USD Million)
Table 48 Japan drug screening market, by sample type, 2018 - 2030 (USD Million)
Table 49 Japan drug screening market, by end-use, 2018 - 2030 (USD Million)
Table 50 China drug screening market, by product type, 2018 - 2030 (USD Million)
Table 51 China drug screening market, by sample type, 2018 - 2030 (USD Million)
Table 52 China drug screening market, by end-use, 2018 - 2030 (USD Million)
Table 53 India drug screening market, by product type, 2018 - 2030 (USD Million)
Table 54 India drug screening market, by sample type, 2018 - 2030 (USD Million)
Table 55 India drug screening market, by end-use, 2018 - 2030 (USD Million)
Table 56 Australia drug screening market, by product type, 2018 - 2030 (USD Million)
Table 57 Australia drug screening market, by sample type, 2018 - 2030 (USD Million)
Table 58 Australia drug screening market, by end-use, 2018 - 2030 (USD Million)
Table 59 South Korea drug screening market, by product type, 2018 - 2030 (USD Million)
Table 60 South Korea drug screening market, by sample type, 2018 - 2030 (USD Million)
Table 61 South Korea drug screening market, by end-use, 2018 - 2030 (USD Million)
Table 62 Thailand drug screening market, by product type, 2018 - 2030 (USD Million)
Table 63 Thailand drug screening market, by sample type, 2018 - 2030 (USD Million)
Table 64 Thailand drug screening market, by end-use, 2018 - 2030 (USD Million)
Table 65 Latin America drug screening market, by region, 2018 - 2030 (USD Million)
Table 66 Latin America drug screening market, by product type, 2018 - 2030 (USD Million)
Table 67 Latin America drug screening market, by sample type, 2018 - 2030 (USD Million)
Table 68 Latin America drug screening market, by end-use, 2018 - 2030 (USD Million)
Table 69 Brazil drug screening market, by product type, 2018 - 2030 (USD Million)
Table 70 Brazil drug screening market, by sample type, 2018 - 2030 (USD Million)
Table 71 Brazil drug screening market, by end-use, 2018 - 2030 (USD Million)
Table 72 Argentina drug screening market, by product type, 2018 - 2030 (USD Million)
Table 73 Argentina drug screening market, by sample type, 2018 - 2030 (USD Million)
Table 74 Argentina drug screening market, by end-use, 2018 - 2030 (USD Million)
Table 75 MEA drug screening market, by region, 2018 - 2030 (USD Million)
Table 76 MEA drug screening market, by product type, 2018 - 2030 (USD Million)
Table 77 MEA drug screening market, by sample type, 2018 - 2030 (USD Million)
Table 78 MEA drug screening market, by end-use, 2018 - 2030 (USD Million)
Table 79 South Africa drug screening market, by product type, 2018 - 2030 (USD Million)
Table 80 South Africa drug screening market, by sample type, 2018 - 2030 (USD Million)
Table 81 South Africa drug screening market, by end-use, 2018 - 2030 (USD Million)
Table 82 Saudi Arabia drug screening market, by product type, 2018 - 2030 (USD Million)
Table 83 Saudi Arabia drug screening market, by sample type, 2018 - 2030 (USD Million)
Table 84 Saudi Arabia drug screening market, by end-use, 2018 - 2030 (USD Million)
Table 85 UAE drug screening market, by product type, 2018 - 2030 (USD Million)
Table 86 UAE drug screening market, by sample type, 2018 - 2030 (USD Million)
Table 87 UAE drug screening market, by end-use, 2018 - 2030 (USD Million)
Table 88 Kuwait drug screening market, by product type, 2018 - 2030 (USD Million)
Table 89 Kuwait drug screening market, by sample type, 2018 - 2030 (USD Million)
Table 90 Kuwait drug screening market, by end-use, 2018 - 2030 (USD Million)
Table 1 List of abbreviation
Table 2 North America drug screening market, by region, 2018 - 2030 (USD Million)
Table 3 North America drug screening market, by product type, 2018 - 2030 (USD Million)
Table 4 North America drug screening market, by sample type, 2018 - 2030 (USD Million)
Table 5 North America drug screening market, by end-use, 2018 - 2030 (USD Million)
Table 6 U.S. drug screening market, by product type, 2018 - 2030 (USD Million)
Table 7 U.S. drug screening market, by sample type, 2018 - 2030 (USD Million)
Table 8 U.S. drug screening market, by end-use, 2018 - 2030 (USD Million)
Table 9 Canada drug screening market, by product type, 2018 - 2030 (USD Million)
Table 10 Canada drug screening market, by sample type, 2018 - 2030 (USD Million)
Table 11 Canada drug screening market, by end-use, 2018 - 2030 (USD Million)
Table 12 Mexico drug screening market, by product type, 2018 - 2030 (USD Million)
Table 13 Mexico drug screening market, by sample type, 2018 - 2030 (USD Million)
Table 14 Mexico drug screening market, by end-use, 2018 - 2030 (USD Million)
Table 15 Europe drug screening market, by region, 2018 - 2030 (USD Million)
Table 16 Europe drug screening market, by product type, 2018 - 2030 (USD Million)
Table 17 Europe drug screening market, by sample type, 2018 - 2030 (USD Million)
Table 18 Europe drug screening market, by end-use, 2018 - 2030 (USD Million)
Table 19 UK drug screening market, by product type, 2018 - 2030 (USD Million)
Table 20 UK drug screening market, by sample type, 2018 - 2030 (USD Million)
Table 21 UK drug screening market, by end-use, 2018 - 2030 (USD Million)
Table 22 Germany drug screening market, by product type, 2018 - 2030 (USD Million)
Table 23 Germany drug screening market, by sample type, 2018 - 2030 (USD Million)
Table 24 Germany drug screening market, by end-use, 2018 - 2030 (USD Million)
Table 25 France drug screening market, by product type, 2018 - 2030 (USD Million)
Table 26 France drug screening market, by sample type, 2018 - 2030 (USD Million)
Table 27 France drug screening market, by end-use, 2018 - 2030 (USD Million)
Table 28 Italy drug screening market, by product type, 2018 - 2030 (USD Million)
Table 29 Italy drug screening market, by sample type, 2018 - 2030 (USD Million)
Table 30 Italy drug screening market, by end-use, 2018 - 2030 (USD Million)
Table 31 Spain drug screening market, by product type, 2018 - 2030 (USD Million)
Table 32 Spain drug screening market, by sample type, 2018 - 2030 (USD Million)
Table 33 Spain drug screening market, by end-use, 2018 - 2030 (USD Million)
Table 34 Denmark drug screening market, by product type, 2018 - 2030 (USD Million)
Table 35 Denmark drug screening market, by sample type, 2018 - 2030 (USD Million)
Table 36 Denmark drug screening market, by end-use, 2018 - 2030 (USD Million)
Table 37 Sweden drug screening market, by product type, 2018 - 2030 (USD Million)
Table 38 Sweden drug screening market, by sample type, 2018 - 2030 (USD Million)
Table 39 Sweden drug screening market, by end-use, 2018 - 2030 (USD Million)
Table 40 Norway drug screening market, by product type, 2018 - 2030 (USD Million)
Table 41 Norway drug screening market, by sample type, 2018 - 2030 (USD Million)
Table 42 Norway drug screening market, by end-use, 2018 - 2030 (USD Million)
Table 43 Asia Pacific drug screening market, by region, 2018 - 2030 (USD Million)
Table 44 Asia Pacific drug screening market, by product type, 2018 - 2030 (USD Million)
Table 45 Asia Pacific drug screening market, by sample type, 2018 - 2030 (USD Million)
Table 46 Aisa Pacific drug screening market, by end-use, 2018 - 2030 (USD Million)
Table 47 Japan drug screening market, by product type, 2018 - 2030 (USD Million)
Table 48 Japan drug screening market, by sample type, 2018 - 2030 (USD Million)
Table 49 Japan drug screening market, by end-use, 2018 - 2030 (USD Million)
Table 50 China drug screening market, by product type, 2018 - 2030 (USD Million)
Table 51 China drug screening market, by sample type, 2018 - 2030 (USD Million)
Table 52 China drug screening market, by end-use, 2018 - 2030 (USD Million)
Table 53 India drug screening market, by product type, 2018 - 2030 (USD Million)
Table 54 India drug screening market, by sample type, 2018 - 2030 (USD Million)
Table 55 India drug screening market, by end-use, 2018 - 2030 (USD Million)
Table 56 Australia drug screening market, by product type, 2018 - 2030 (USD Million)
Table 57 Australia drug screening market, by sample type, 2018 - 2030 (USD Million)
Table 58 Australia drug screening market, by end-use, 2018 - 2030 (USD Million)
Table 59 South Korea drug screening market, by product type, 2018 - 2030 (USD Million)
Table 60 South Korea drug screening market, by sample type, 2018 - 2030 (USD Million)
Table 61 South Korea drug screening market, by end-use, 2018 - 2030 (USD Million)
Table 62 Thailand drug screening market, by product type, 2018 - 2030 (USD Million)
Table 63 Thailand drug screening market, by sample type, 2018 - 2030 (USD Million)
Table 64 Thailand drug screening market, by end-use, 2018 - 2030 (USD Million)
Table 65 Latin America drug screening market, by region, 2018 - 2030 (USD Million)
Table 66 Latin America drug screening market, by product type, 2018 - 2030 (USD Million)
Table 67 Latin America drug screening market, by sample type, 2018 - 2030 (USD Million)
Table 68 Latin America drug screening market, by end-use, 2018 - 2030 (USD Million)
Table 69 Brazil drug screening market, by product type, 2018 - 2030 (USD Million)
Table 70 Brazil drug screening market, by sample type, 2018 - 2030 (USD Million)
Table 71 Brazil drug screening market, by end-use, 2018 - 2030 (USD Million)
Table 72 Argentina drug screening market, by product type, 2018 - 2030 (USD Million)
Table 73 Argentina drug screening market, by sample type, 2018 - 2030 (USD Million)
Table 74 Argentina drug screening market, by end-use, 2018 - 2030 (USD Million)
Table 75 MEA drug screening market, by region, 2018 - 2030 (USD Million)
Table 76 MEA drug screening market, by product type, 2018 - 2030 (USD Million)
Table 77 MEA drug screening market, by sample type, 2018 - 2030 (USD Million)
Table 78 MEA drug screening market, by end-use, 2018 - 2030 (USD Million)
Table 79 South Africa drug screening market, by product type, 2018 - 2030 (USD Million)
Table 80 South Africa drug screening market, by sample type, 2018 - 2030 (USD Million)
Table 81 South Africa drug screening market, by end-use, 2018 - 2030 (USD Million)
Table 82 Saudi Arabia drug screening market, by product type, 2018 - 2030 (USD Million)
Table 83 Saudi Arabia drug screening market, by sample type, 2018 - 2030 (USD Million)
Table 84 Saudi Arabia drug screening market, by end-use, 2018 - 2030 (USD Million)
Table 85 UAE drug screening market, by product type, 2018 - 2030 (USD Million)
Table 86 UAE drug screening market, by sample type, 2018 - 2030 (USD Million)
Table 87 UAE drug screening market, by end-use, 2018 - 2030 (USD Million)
Table 88 Kuwait drug screening market, by product type, 2018 - 2030 (USD Million)
Table 89 Kuwait drug screening market, by sample type, 2018 - 2030 (USD Million)
Table 90 Kuwait drug screening market, by end-use, 2018 - 2030 (USD Million)
LIST OF FIGURES
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews in North America
Fig. 5 Primary interviews in Europe
Fig. 6 Primary interviews in APAC
Fig. 7 Primary interviews in Latin America
Fig. 8 Primary interviews in MEA
Fig. 9 Market research approaches
Fig. 10 Value-chain-based sizing & forecasting
Fig. 11 QFD modeling for market share assessment
Fig. 12 Market formulation & validation
Fig. 13 Drug screening market: market outlook
Fig. 14 Drug screening competitive insights
Fig. 15 Parent market outlook
Fig. 16 Related/ancillary market outlook
Fig. 17 Drug screening market driver impact
Fig. 18 Drug screening market restraint impact
Fig. 19 Drug screening market: Product type movement analysis
Fig. 20 Drug screening market: Product type outlook and key takeaways
Fig. 21 Instruments market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 22 Immunoassays analyzers market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 23 Chromatography instruments market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 24 Breath analyzers market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 25 Fuel cell breath analyzers market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 26 Semi-conductor breath analyzers market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 27 Others breath analyzers market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 28 Rapid testing devices estimates and forecast, 2018 - 2030 (USD Million)
Fig. 29 Urine testing devices estimates and forecast, 2018 - 2030 (USD Million)
Fig. 30 Drug testing cups estimates and forecast, 2018 - 2030 (USD Million)
Fig. 31 Dip cards estimates and forecast, 2018 - 2030 (USD Million)
Fig. 32 Drug testing cassettes estimates and forecast, 2018 - 2030 (USD Million)
Fig. 33 Oral fluid testing devices estimates and forecast, 2018 - 2030 (USD Million)
Fig. 34 Consumables estimates and forecast, 2018 - 2030 (USD Million)
Fig. 35 Assay kits estimates and forecast, 2018 - 2030 (USD Million)
Fig. 36 Sample collection devices estimates and forecast, 2018 - 2030 (USD Million)
Fig. 37 Calibrators & controls estimates and forecast, 2018 - 2030 (USD Million)
Fig. 38 Other consumables estimates and forecast, 2018 - 2030 (USD Million)
Fig. 39 Services and others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 40 Drug screening market: Sample type movement analysis
Fig. 41 Drug screening market: Sample type outlook and key takeaways
Fig. 42 Urine samples market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 43 Breath samples estimates and forecast, 2018 - 2030 (USD Million)
Fig. 44 Oral fluid samples market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 45 Hair samples estimates and forecast, 2018 - 2030 (USD Million)
Fig. 46 Other samples estimates and forecast, 2018 - 2030 (USD Million)
Fig. 47 Drug screening market: End-use movement analysis
Fig. 48 Drug screening market: End-use outlook and key takeaways
Fig. 49 Hospitals market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 50 Criminal justice and law enforcement agencies estimates and forecast, 2018 - 2030 (USD Million)
Fig. 51 Workplaces market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 52 Drug treatment centers market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 53 Individual users market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 54 Pain management centers market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 55 Schools & colleges market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 56 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 57 Global drug screening market: Regional movement analysis
Fig. 58 Global drug screening market: Regional outlook and key takeaways
Fig. 59 Global drug screening market share and leading players
Fig. 60 North America, by country
Fig. 61 North America market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 62 U.S. key country dynamics
Fig. 63 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 64 Canada key country dynamics
Fig. 65 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 66 Mexico key country dynamics
Fig. 67 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 68 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 69 UK key country dynamics
Fig. 70 UK market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 71 Germany key country dynamics
Fig. 72 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 73 France key country dynamics
Fig. 74 France market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 75 Italy key country dynamics
Fig. 76 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 77 Spain key country dynamics
Fig. 78 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 79 Denmark key country dynamics
Fig. 80 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 81 Sweden key country dynamics
Fig. 82 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 83 Norway key country dynamics
Fig. 84 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 85 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 86 Japan key country dynamics
Fig. 87 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 88 China key country dynamics
Fig. 89 China market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 90 India key country dynamics
Fig. 91 India market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 92 Australia key country dynamics
Fig. 93 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 94 South Korea key country dynamics
Fig. 95 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 96 Thailand key country dynamics
Fig. 97 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 98 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 99 Brazil key country dynamics
Fig. 100 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 101 Argentina key country dynamics
Fig. 102 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 103 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 104 South Africa key country dynamics
Fig. 105 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 106 Saudi Arabia key country dynamics
Fig. 107 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 108 UAE key country dynamics
Fig. 109 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 110 Kuwait key country dynamics
Fig. 111 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 112 Market share of key market players- Global drug screening market
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews in North America
Fig. 5 Primary interviews in Europe
Fig. 6 Primary interviews in APAC
Fig. 7 Primary interviews in Latin America
Fig. 8 Primary interviews in MEA
Fig. 9 Market research approaches
Fig. 10 Value-chain-based sizing & forecasting
Fig. 11 QFD modeling for market share assessment
Fig. 12 Market formulation & validation
Fig. 13 Drug screening market: market outlook
Fig. 14 Drug screening competitive insights
Fig. 15 Parent market outlook
Fig. 16 Related/ancillary market outlook
Fig. 17 Drug screening market driver impact
Fig. 18 Drug screening market restraint impact
Fig. 19 Drug screening market: Product type movement analysis
Fig. 20 Drug screening market: Product type outlook and key takeaways
Fig. 21 Instruments market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 22 Immunoassays analyzers market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 23 Chromatography instruments market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 24 Breath analyzers market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 25 Fuel cell breath analyzers market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 26 Semi-conductor breath analyzers market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 27 Others breath analyzers market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 28 Rapid testing devices estimates and forecast, 2018 - 2030 (USD Million)
Fig. 29 Urine testing devices estimates and forecast, 2018 - 2030 (USD Million)
Fig. 30 Drug testing cups estimates and forecast, 2018 - 2030 (USD Million)
Fig. 31 Dip cards estimates and forecast, 2018 - 2030 (USD Million)
Fig. 32 Drug testing cassettes estimates and forecast, 2018 - 2030 (USD Million)
Fig. 33 Oral fluid testing devices estimates and forecast, 2018 - 2030 (USD Million)
Fig. 34 Consumables estimates and forecast, 2018 - 2030 (USD Million)
Fig. 35 Assay kits estimates and forecast, 2018 - 2030 (USD Million)
Fig. 36 Sample collection devices estimates and forecast, 2018 - 2030 (USD Million)
Fig. 37 Calibrators & controls estimates and forecast, 2018 - 2030 (USD Million)
Fig. 38 Other consumables estimates and forecast, 2018 - 2030 (USD Million)
Fig. 39 Services and others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 40 Drug screening market: Sample type movement analysis
Fig. 41 Drug screening market: Sample type outlook and key takeaways
Fig. 42 Urine samples market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 43 Breath samples estimates and forecast, 2018 - 2030 (USD Million)
Fig. 44 Oral fluid samples market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 45 Hair samples estimates and forecast, 2018 - 2030 (USD Million)
Fig. 46 Other samples estimates and forecast, 2018 - 2030 (USD Million)
Fig. 47 Drug screening market: End-use movement analysis
Fig. 48 Drug screening market: End-use outlook and key takeaways
Fig. 49 Hospitals market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 50 Criminal justice and law enforcement agencies estimates and forecast, 2018 - 2030 (USD Million)
Fig. 51 Workplaces market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 52 Drug treatment centers market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 53 Individual users market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 54 Pain management centers market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 55 Schools & colleges market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 56 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 57 Global drug screening market: Regional movement analysis
Fig. 58 Global drug screening market: Regional outlook and key takeaways
Fig. 59 Global drug screening market share and leading players
Fig. 60 North America, by country
Fig. 61 North America market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 62 U.S. key country dynamics
Fig. 63 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 64 Canada key country dynamics
Fig. 65 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 66 Mexico key country dynamics
Fig. 67 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 68 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 69 UK key country dynamics
Fig. 70 UK market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 71 Germany key country dynamics
Fig. 72 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 73 France key country dynamics
Fig. 74 France market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 75 Italy key country dynamics
Fig. 76 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 77 Spain key country dynamics
Fig. 78 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 79 Denmark key country dynamics
Fig. 80 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 81 Sweden key country dynamics
Fig. 82 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 83 Norway key country dynamics
Fig. 84 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 85 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 86 Japan key country dynamics
Fig. 87 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 88 China key country dynamics
Fig. 89 China market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 90 India key country dynamics
Fig. 91 India market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 92 Australia key country dynamics
Fig. 93 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 94 South Korea key country dynamics
Fig. 95 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 96 Thailand key country dynamics
Fig. 97 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 98 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 99 Brazil key country dynamics
Fig. 100 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 101 Argentina key country dynamics
Fig. 102 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 103 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 104 South Africa key country dynamics
Fig. 105 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 106 Saudi Arabia key country dynamics
Fig. 107 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 108 UAE key country dynamics
Fig. 109 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 110 Kuwait key country dynamics
Fig. 111 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 112 Market share of key market players- Global drug screening market
